Cleared Traditional

K972669 - MTM BIOSCANNER 1000 TEST SYSTEM CONSIST...

K972669 is an FDA 510(k) clearance for MTM BIOSCANNER 1000 TEST SYSTEM CONSIST..., manufactured by Polymer Technology Systems, Inc.. The device is a Class 2 Chemistry device with product code CGA cleared through the Traditional 510(k) pathway after a 190-day FDA review.

K972669 · Polymer Technology Systems, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1998
Decision
190d
Days
Class 2
Risk

K972669 is an FDA 510(k) clearance for the MTM BIOSCANNER 1000 TEST SYSTEM CONSISTING OF MTM BIOSCANNER 1000 METER, MTM .... Classified as Glucose Oxidase, Glucose (product code CGA), Class II - Special Controls.

Submitted by Polymer Technology Systems, Inc. (Indianapolis, US). The FDA issued a Cleared decision on January 22, 1998 after a review of 190 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Polymer Technology Systems, Inc. devices

FDA 510(k) Submission Details - K972669

510(k) Number K972669 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 16, 1997
Decision Date January 22, 1998
Days to Decision 190 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
102d slower than avg
Panel avg: 88d · This submission: 190d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CGA Device Classification - Class 2, Special Controls

Product Code CGA Glucose Oxidase, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGA Glucose Oxidase, Glucose

All 257
Devices cleared under the same product code (CGA) and FDA review panel - the closest regulatory comparables to K972669.
IN TOUCH DIABETES MANAGEMENT SOFTWARE
K984527 · Lifescan, Inc. · Apr 1999
GLUCOMETER ELITE XL BLOOD GLUCOSE METER
K984006 · Bayer Corp. · Mar 1999
ONE TOUCH II HOSPITAL BLOOD GLUCOSE MONITORING SYSTEM
K974451 · Lifescan, Inc. · Jan 1998
ONE TOUCH II HOSPITAL BLOOD GLUCOSE MONITORING SYSTEM DATA DOCK
K972473 · Lifescan, Inc. · Dec 1997
AVL OMNI ANALYZER
K972733 · Avl Scientific Corp. · Sep 1997
SURESTEP PRO BLOOD GLUCOSE MONITORING SYSTEM
K970556 · Lifescan, Inc. · May 1997